Cell death induced in a human glioblastoma cell line by p(65) + Be neutrons combined with cisplatin

Life Sciences

Volumn 79, Issue 6, 2006, Pages 513-518

  Benzina, Sami ^a   Fischer, Barbara ^a   Miternique Grosse, Anne ^b   Dufour, Patrick ^a   Denis, Jean Marc ^c   Bergerat, Jean Pierre ^a   Gueulette, John ^c   Bischoff, Pierre ^a  

^a IRCAD   (France)

^b UNIVERSITÉ DE STRASBOURG   (France)

^c UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

Author keywords

Apoptosis; Cisplatin; LET; Neutrons; Premature senescence

Indexed keywords

CISPLATIN;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CELL AGING; CELL DEATH; CELL SURVIVAL; CONTROLLED STUDY; CYTOTOXICITY; DRUG EFFICACY; DRUG POTENCY; FAST NEUTRON THERAPY; GLIOBLASTOMA; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IN VITRO STUDY; IRRADIATION; LINEAR ENERGY TRANSFER; RADIATION EXPOSURE;

ANTINEOPLASTIC AGENTS; APOPTOSIS; CASPASE 3; CASPASES; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; CISPLATIN; CULTURE MEDIA; DOSE-RESPONSE RELATIONSHIP, DRUG; DOSE-RESPONSE RELATIONSHIP, RADIATION; FAST NEUTRONS; GLIOBLASTOMA; HUMANS;

EID: 33745213125     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lfs.2006.01.037     Document Type: Article

References (31)

1. Akudugu J.M., Binder A., Serafin A., Slabbert J., Giese A., and Böhm L. Changes in G1-phase populations in human glioblastoma and neuroblastoma cell lines influence p(66)/Be neutron-induced micronucleus yield. Life Sciences 75 (2004) 623-632
2. Attardi L.D., De Vries A., and Jacks T. Activation of the p53-dependent G1 checkpoint response in mouse embryo fibroblasts depends on the specific DNA damage inducer. Oncogene 23 (2004) 973-980
3. Bartelink H., Schellens J.H.M., and Verheij M. The combined use of radiotherapy and chemotherapy in the treatment of solid tumors. European Journal of Cancer 38 (2002) 216-222
4. Burkart W., Jung T., and Frash G. Damage pattern as a function of radiation quality and other factors. Comptes-Rendus de l'Académie des Sciences Paris-Life Sciences 322 (1999) 89-101
5. Debatin K.M. Apoptosis pathways in cancer and cancer therapy. Cancer Immunology Immunotherapy 53 (2004) 153-159
6. Dewey W.C., Ling C.C., and Meyn R.E. Radiation-induced apoptosis: relevance to radiotherapy. International Journal of Radiation Oncology Biology Physics 33 (1995) 781-796
7. Durdux C. Cisplatin and derivatives with radiation therapy. Cancer/Radiothérapie 8 suppl 1 (2004) S88-S94
8. Eom Y.-W., Kim M.A., Park M.J., Kwon H.J., Sohn S., Kim W.-H., Yoon G., and Choi K.S. Two modes of cell death induced by doxorubicin: apoptosis and cell death through mitotic catastrophe accompanied by senescence-like phenotype. Oncogene (2005) 1-13
9. Fischer B., Benzina S., Ganansia-Leymarie V., Denis J.M., Bergerat J.P., Dufour P., Gueulette J., and Bischoff P. Cisplatin enhances the cytotoxicity of fast neutrons in a murine lymphoma cell line. Canadian Journal of Physiology and Pharmacology 82 (2004) 140-145
10. Furuta T., Ueda T., Aune G., Sarasin A., Kraemer K.H., and Pommier Y. Transcription-coupled nucleotide excision repair as a determinant of cisplatin sensitivity of human cells. Cancer Research 62 (2002) 4899-4902
11. Gonzalez V.M., Fuertes M.A., Alonso C., and Perez J.M. Is cisplatin-induced cell death always produced by apoptosis?. Molecular Pharmacology 59 (2001) 657-663
12. Goodhead D.T. Mechanisms for the biological effectiveness of high-LET radiations. Journal of Radiation Research 40 (1999) 1-13
13. Hennequin C., and Favaudon V. Biological basis for chemo-radiotherapy interactions. European Journal of Cancer 38 (2002) 223-230
14. Holgersson A., Jernberg A.R., Persson L.M., Edgren M.R., Lewensohn R., Nilsson A., Brahme A., and Meijer A.E. Low and high radiation-induced apoptosis in M059J and M059K cells. International Journal of Radiation Biology 79 (2003) 611-621
15. Iwadate Y., Mizoe J.-E., Osaka Y., Yamaura A., and Tsujii H. High linear energy transfer carbon radiation effectively kills cultured glioma cells with either mutant of wild-type p53. International Journal of Radiation Oncology Biology Physics 50 (2001) 803-808
16. Kaufmann S.H., and Earnshaw W.C. Induction of apoptosis by cancer chemotherapy. Experimental Cell Research 256 (2002) 42-49
17. Kim H.E., Krug M.A., Han I., Ensley J., Yoo G.H., Forman J.D., and Kim H.-R.C. Neutron radiation enhances cisplatin cytotoxicity independently of apoptosis in human head and neck carcinoma cells. Clinical Cancer Research 6 (2000) 4142-4147
18. Kim R., Tanabe K., Uchida Y., Emi M., Inoue H., and Toge T. Current statute of the molecular mechanisms of anticancer drug-induced apoptosis. Cancer Chemotherapy Pharmacology 50 (2002) 343-352
19. Kobayashi K., Frohlich H., Usami N., Takakura K., and Le Sech C. Enhancement of X-rays-induced breaks in DNA bound to molecules containing platinum: a possible application to hadrontherapy. Radiation Research 157 (2002) 32-37
20. Lawrence T.S., Blackstock A.W., and McGinn C. The mechanism of action of radiosensitization of conventional chemotherapeutic agents. Seminars in Radiation Oncololy 13 (2003) 13-21
21. Milas, L., Mason, K.A., Liao, Z., Ang, K.K., 2003. Chemoradiotherapy: emerging treatment improvement strategies. Head and Neck, H. T. Hoffmann, N. T. (Ed), Improvement strategies in chemoradiotherapy, Wiley Periodicals, pp 152-167.
22. Mustonen R., Bouvier G., Wolber G., Stöhr M., Peschke P., and Bartsch H.A. Comparison of gamma and neutron irradiation on Raji cells: effects on DNA damage, repair, cell cycle distribution and lethality. Mutation Research 429 (1999) 169-179
23. Nicoletti I., Migliorati G., Pagliacci M.C., Grignani F., and Riccardi C. A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. Journal of Immunology Methods 139 (1991) 271-279
24. Orecchia R., Krengli M., Jereczek-Fossa B.A., Franzetti S., and Gerard J.P. Clinical and research validity of hadrontherapy with ion beams. Critical Reviews in Oncology/Hematology 51 (2004) 81-90
25. Pouget J.P., and Mather S.J. General aspects of the cellular response to low- and high-LET radiation. European Journal of Nuclear Medicine 28 (2001) 541-561
26. Radford I.R. DNA lesion complexicity and induction of apoptosis by ionising radiation 2002. International Journal of Radiation Biology 78 (2002) 457-466
27. Roninson I.B. Tumor cell senescence in cancer treatment. Cancer Research 263 (2003) 2705-2715
28. Scalliet P.G.M., Remouchmaps V., Lhoas F., Van Glabbeke M., Curran D., Ledent T., Wambersie A., Richard F., and Van Cangh P. A retrospective analysis of the results of p(65) + Be neutrontherapy for the treatment of prostate adenocarcinoma at the cyclotron of Louvain-la-Neuve. Part I: survival and progression-free survival. Cancer/Radiothérapie 5 (2001) 262-272
29. Taghian A., Suit H., Pardo F., Gioioso D., Tomkinson K., Dubois, and Gerweck L. In vitro intrinsic radiation sensitivity of glioblastoma multiforme. International Journal of Radiation Oncology Biology Physics 23 (1992) 55-62
30. Tsuchida Y., Tsuboi K., Ohyama H., Ohno T., Nose T., and Ando K. Cell death induced by high-linear-energy transfer carbon beams in human glioblastoma cell lines. Brain Tumor Pathology 15 (1998) 71-76
31. Zhivotovsky B., Joseph B., and Orrenius S. Tumor radiosensitivity and apoptosis. Experimental Cell Research 248 (1999) 10-17